Literature DB >> 23929267

Hepatitis C virus-related lymphoproliferative disorders encompass a broader clinical and morphological spectrum than previously recognized: a clinicopathological study.

Manuela Mollejo1, Javier Menárguez2, Pablo Guisado-Vasco3, Leyre Bento4, Patrocinio Algara5, Santiago Montes-Moreno6, María S Rodriguez-Pinilla7, Miguel A Cruz8, Felipe Casado9, Carlos Montalbán3, Miguel A Piris6.   

Abstract

We describe a retrospective series of B-cell lymphoproliferative disorders associated with hepatitis C virus infection. In addition to splenic marginal zone lymphoma, follicular lymphoma and diffuse large B-cell lymphoma, all of which showed some specific features, we found two poorly described groups of cases. The first featured disseminated marginal zone lymphoma without splenic marginal zone lymphoma features, defying the current marginal zone lymphoma classification; the other consisted of monoclonal B lymphocytes in the peripheral blood, bone marrow or other tissues, with no clinical or histological evidence of lymphoma, and exhibiting a pattern that requires proper identification in order to avoid the misdiagnosis of the lymphoma. Diagnosis of hepatitis C virus infection-associated lymphoproliferative disorders requires the integration of clinical, pathological and molecular findings to establish an adequate diagnosis and decide the appropriate therapy to be applied.

Entities:  

Mesh:

Year:  2013        PMID: 23929267     DOI: 10.1038/modpathol.2013.120

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Primary follicular lymphoma of the spleen incidentally found in a patient with alcohol- and hepatitis C-related liver cirrhosis.

Authors:  Ikuo Matsuda; Masaya Okada; Takayuki Inoue; Tazuko Tokugawa; Hiroyasu Ogawa; Seiichi Hirota
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

2.  The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.

Authors:  Luca Arcaini; Davide Rossi; Marco Lucioni; Marta Nicola; Alessio Bruscaggin; Valeria Fiaccadori; Roberta Riboni; Antonio Ramponi; Virginia V Ferretti; Stefania Cresta; Gloria Margiotta Casaluci; Maurizio Bonfichi; Manuel Gotti; Michele Merli; Aldo Maffi; Mariarosa Arra; Marzia Varettoni; Sara Rattotti; Lucia Morello; Maria Luisa Guerrera; Roberta Sciarra; Gianluca Gaidano; Mario Cazzola; Marco Paulli
Journal:  Haematologica       Date:  2014-11-07       Impact factor: 9.941

Review 3.  Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.

Authors:  Romeo-Gabriel Mihăilă
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 4.  Relationships between lymphomas linked to hepatitis C virus infection and their microenvironment.

Authors:  Antonino Carbone; Annunziata Gloghini
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

5.  A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia.

Authors:  Li Zhang; Sindhuja Marupudi; Tamil Kuppusamy; William LaRosa; Paul Turer; Meyer Heyman; Lois Arend
Journal:  Case Rep Nephrol Dial       Date:  2014-08-14

6.  Hepatitis C virus positive diffuse large B-cell lymphomas have distinct molecular features and lack BCL2 translocations.

Authors:  Carlo Visco; Jinfen Wang; Maria Chiara Tisi; Lijuan Deng; Emanuele S G D'Amore; Alexandar Tzankov; Santiago Montes-Moreno; Karen Dybkær; Govind Bhagat; Eric D Hsi; J Han van Krieken; Maurilio Ponzoni; Andrés J M Ferreri; Michael B Møller; Miguel A Piris; L Jeffrey Medeiros; Zijun Y Xu-Monette; Ken H Young
Journal:  Br J Cancer       Date:  2017-09-26       Impact factor: 7.640

Review 7.  How to Diagnose and Treat CD5-Positive Lymphomas Involving the Spleen.

Authors:  José Cabeçadas; Victor E Nava; Joao L Ascensao; Maria Gomes da Silva
Journal:  Curr Oncol       Date:  2021-11-11       Impact factor: 3.677

Review 8.  Infections and Follicular Lymphoma: is there a Link?

Authors:  Francesco Zallio; Giulia Limberti; Marco Ladetto
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-05-01       Impact factor: 2.576

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.